HOME >> BIOLOGY >> NEWS
New amfAR research grants to optimize HIV treatment

NEW YORK -- amfAR, The Foundation for AIDS Research, will grant almost $1.2 million for 10 new research projects aimed at increasing understanding of the social and biological factors that influence the treatment of HIV/AIDS, Dr. Rowena Johnston, amfARs vice president of research, announced today.

Among those projects is a study exploring the potential benefits of maraviroc, a new antiretroviral drug expected to be approved by the FDA soon. Maraviroc works by blocking the cell surface protein CCR5 and thus preventing the virus from entering cells. amfAR funded research 10 years ago that played a leading role in spurring the development of maraviroc.

The drug also has the potential to prevent disease progression by reducing the activation state of the immune system, said Dr. Nancy Shulman of Stanford University and the Palo Alto VA Medical Center, who received the grant.

Immune activation has been implicated in promoting HIV disease, she said. If maraviroc can decrease HIV disease both by blocking HIV entry into cells as well as decreasing immune activation, this could have implications for broadening the use of maraviroc even in patients who might otherwise seem to be unsuitable candidates for the drug.

amfAR will also fund several projects related to the social factors contributing to HIV infection, including one that examines how stigma associated with HIV affects the level of care that patients receive.

Although progress has been made over the past 25 years in protecting the rights of people with AIDS, the stigma associated with being HIV positive can still contribute to lower quality health care in those with HIV infection, Dr Johnston said. New research funded by amfAR and being conducted by Dr. Jennifer Sayles of the University of California, Los Angeles aims to identify factors that contribute to HIV-related stigma in women, with the long-term goal of improving the quality of their health care.

<
'"/>

Contact: Donald Kaplan
donald.kaplan@amfar.org
212-806-1602
amfAR, The Foundation for AIDS Research
21-Jun-2007


Page: 1 2 3 4 5 6

Related biology news :

1. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
2. Saudi Arabias KAUST names WHOI first research partner
3. Multinational research: protecting ecology means understanding people, too
4. Newly created cancer stem cells could aid breast cancer research
5. Carnegie Mellons Peter Adams receives EPA research grant
6. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
7. Innovative tagging technique may help researchers better protect fish stocks
8. Penn researchers discover how key protein stops inflammation
9. UCF research links proteins, stem cells and potential Alzheimers treatment
10. ASU researchers partner with UOP to make biofuel for military jets a reality
11. Einstein researchers prototype vaccine could provide improved protection against tuberculosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New amfAR research grants optimize HIV treatment

(Date:10/30/2014)... news release is available in German . ... as individuals prompt our fellow humans to behave socially? ... social dilemmas in game theory. Previous studies assumed that ... groups. Nonetheless, scientists from the Max Planck Institute for ... can exert an influence on the cooperative behaviour of ...
(Date:10/30/2014)... New York | Heidelberg, 30 October 2014 Biological ... a better understanding of adsorption of solution ions ... biological cells. Now, a new study provides a ... and surrounding solution ions. Joanna Kotyńska and Zbigniew ... the authors of a study describing these findings, ...
(Date:10/29/2014)... date, researchers have used DNA sequencing to uncover dozens ... Buxbaum, Ph.D., Icahn School of Medicine at Mount Sinai, ... Harvard and MIT, and their colleagues examined more than ... people. They identified changes in 107 genes that are ... disorder (ASD) – a jump from the nine genes ...
Breaking Biology News(10 mins):Together we are strong -- or insufferable 2Together we are strong -- or insufferable 3Together we are strong -- or insufferable 4Ion adsorption matter in biology 2
(Date:10/31/2014)... 2014  Tavistock Development Co. (TDC), a diversified ... groundbreaking of the GuideWell Innovation Center ... The 92,000-square-foot, three-story facility is the first multi-tenant ... designed specifically for life sciences, health innovation, and ... 650-acre Lake Nona Medical City, near the Sanford-Burnham ...
(Date:10/30/2014)... , October 30, 2014 Investor-Edge ... Inc. (NYSE MKT: ONVO), Medivation Inc. (NASDAQ: ... Synthetic Biologics Inc. (NYSE MKT: SYN), and Ironwood Pharmaceuticals ... can be accessed at: http://investor-edge.com/register . ... at 4,549.23, down 0.33%, the Dow Jones Industrial Average ...
(Date:10/30/2014)... October 30, 2014 2014 Deep ... Industryā€¯ is a professional and in-depth research report ... basic Naltrexone HCL information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
(Date:10/30/2014)... Diego, CA (PRWEB) October 30, 2014 ... announced today that they have manually curated public data ... and non profit customers. the data is now ... manually curates and unifies public and internal data sources ... value and knowledge out of the data that becomes ...
Breaking Biology Technology:GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3Rancho BioSciences Manually Curated TCGA Data Sets Available 2
Cached News: